切换至 "中华医学电子期刊资源库"

中华脑血管病杂志(电子版) ›› 2022, Vol. 16 ›› Issue (01) : 1 -7. doi: 10.11817/j.issn.1673-9248.2022.01.001

述评

2021年中国卒中临床转化研究重要进展巡礼
傅瑜1, 马新然1, 黄骁1, 樊东升1,()   
  1. 1. 100191 北京大学第三医院神经内科
  • 收稿日期:2022-01-18 出版日期:2022-02-01
  • 通信作者: 樊东升

An overview of significant advance of Chinese clinical stroke research in 2021

Yu Fu1, Xinran Ma1, Xiao Huang1   

  • Received:2022-01-18 Published:2022-02-01
引用本文:

傅瑜, 马新然, 黄骁, 樊东升. 2021年中国卒中临床转化研究重要进展巡礼[J]. 中华脑血管病杂志(电子版), 2022, 16(01): 1-7.

Yu Fu, Xinran Ma, Xiao Huang. An overview of significant advance of Chinese clinical stroke research in 2021[J]. Chinese Journal of Cerebrovascular Diseases(Electronic Edition), 2022, 16(01): 1-7.

1
Leng X, Hurford R, Feng X, et al. Intracranial arterial stenosis in Caucasian versus Chinese patients with TIA and minor stroke: two contemporaneous cohorts and a systematic review [J]. J Neurol Neurosurg Psychiatry, 2021, 92(6): 590-597.
2
Neal B, Wu Y, Feng X, et al. Effect of salt substitution on cardiovascular events and death [J]. N Engl J Med, 2021, 385(12): 1067-1077.
3
Cao Y, Su N, Zhang D, et al. Correlation between total homocysteine and cerebral small vessel disease: a Mendelian randomization study [J]. Eur J Neurol, 2021, 28(6): 1931-1938.
4
Xu J, Dai L, Zhang Y, et al. Severity of nonalcoholic fatty liver disease and risk of future ischemic stroke events [J]. Stroke, 2021, 52(1): 103-110.
5
Tao B, Yang P, Wang C, et al. Fetal exposure to the Great Chinese Famine and risk of ischemic stroke in midlife [J]. Eur J Neurol, 2021, 28(4): 1244-1252.
6
Lin CH, Lai JN, Lee IC, et al. Kawasaki disease may increase the risk of subsequent cerebrovascular disease [J]. Stroke, 2021, online ahead of print.
7
Li KY, Chou MC, Wei JC, et al. Newly diagnosed leptospirosis and subsequent hemorrhagic stroke: a nationwide population-based cohort study [J]. Stroke, 2021, 52(3): 913-921.
8
Liu Y, Cheng P, Liu N, et al. Neuroticism increases the risk of stroke: Mendelian randomization study [J]. Stroke, 2021, 52(11): e742-e743.
9
Tian DY, Zhang LJ, Zhuang ZH, et al. A Mendelian randomization analysis of the relationship between cardioembolic risk factors and ischemic stroke [J]. Sci Rep, 2021, 11(1): 14583.
10
Tian DY, Zhang LJ, Zhuang ZH, et al. A two-sample Mendelian randomization analysis of heart rate variability and cerebral small vessel disease [J]. J Clin Hypertens, 2021, 23(8): 1608-1614.
11
Zhang F, Wang K, Du P, et al. Risk of stroke in cancer survivors: a meta-analysis of population-based cohort studies [J]. Neurology, 2021, 96(4): e513-e526.
12
Lu X, Niu X, Shen C, et al. Development and validation of a polygenic risk score for stroke in the Chinese population [J]. Neurology, 2021, 97(6): e619-e628.
13
Chen Y, Li J, Dang C, et al. Impact of stroke center certification on rt-PA thrombolysis after acute ischemic stroke in South China from 2015 to 2020 [J]. Int J Stroke, 2021, 17474930211031440.
14
Sui Y, Luo J, Dong C, et al. Implementation of regional Acute Stroke Care Map increases thrombolysis rates for acute ischaemic stroke in Chinese urban area in only 3 months [J]. Stroke Vasc Neurol, 2021, 6(1): 87-94.
15
Qin H, Chen Y, Liu G, et al. Management characteristics and prognosis after stroke in China: findings from a large nationwide stroke registry [J]. Stroke Vasc Neurol, 2021, 6(1): 1-9.
16
Jia B, Ren Z, Mokin M, et al. Current status of endovascular treatment for acute large vessel occlusion in China: a real-world nationwide registry [J]. Stroke, 2021, 52(4): 1203-1212.
17
Zi W, Qiu Z, Li F, et al. Effect of endovascular treatment alone vs intravenous alteplase plus endovascular treatment on functional independence in patients with acute ischemic stroke: the DEVT randomized clinical trial [J]. JAMA, 2021, 325(3): 234-243.
18
Tian B, Tian X, Shi Z, et al. Clinical and imaging indicators of hemorrhagic transformation in acute ischemic stroke after endovascular thrombectomy [J]. Stroke, 2021, online ahead of print.
19
Geng C, Li SD, Zhang DD, et al. Endovascular thrombectomy versus bridging thrombolysis: real-world efficacy and safety analysis based on a nationwide registry study [J]. J Am Heart Assoc, 2021, 10(3): e018003.
20
Tong X, Wang Y, Fiehler J, et al. Thrombectomy versus combined thrombolysis and thrombectomy in patients with acute stroke: a matched-control study [J]. Stroke, 2021, 52(5): 1589-1600.
21
Sang HF, Yuan JJ, Qiu ZM, et al. Association between time to endovascular therapy and outcomes in patients with acute basilar artery occlusion [J]. Neurology, 2021, 97(22): e2152-e2163.
22
Li F, Sang H, Song J, et al. One-year outcome after endovascular treatment for acute basilar artery occlusion [J]. Stroke, 2022, 53(1):e9-e13.
23
Yang B, Ma Y, Wang T, et al. Carotid endarterectomy and stenting in a Chinese population: safety outcome of the revascularization of extracranial carotid artery stenosis trial [J]. Transl Stroke Res, 2021, 12(2): 239-247.
24
Wang Y, Meng X, Wang A, et al. Ticagrelor versus clopidogrel in CYP2C19 loss-of-function carriers with stroke or TIA [J]. N Engl J Med, 2021, 385(27): 2520-2530.
25
Li ZX, Xiong Y, Gu HQ, et al. P2Y12 inhibitors plus aspirin versus aspirin alone in patients with minor stroke or high-risk transient ischemic attack [J]. Stroke, 2021, 52(7): 2250-2257.
26
Wang Y, Pan Y, Li H, et al. Efficacy and safety of ticagrelor and aspirin in patients with Moderate ischemic stroke: an exploratory analysis of the THALES randomized clinical trial [J]. JAMA Neurol, 2021, 78(9): 1091-1098.
27
Pan Y, Wangqin R, Li H, et al. F2R polymorphisms and clopidogrel efficacy and safety in patients with minor stroke or TIA [J]. Neurology, 2021, 96(1): e1-e9.
28
Dai L, Xu J, Yan H, et al. Application of age, body mass index, chronic kidney disease, diabetes, and genotyping score for efficacy of clopidogrel: secondary analysis of the CHANCE trial [J]. Stroke, 2022, 53(2):465-472.
29
Zhu W, Ye Z, Chen S, et al. Comparative effectiveness and safety of non-vitamin K antagonist oral anticoagulants in atrial fibrillation patients [J]. Stroke, 2021, 52(4): 1225-1233.
30
Yang WY, Li YF, Wang ZR, et al. Combined therapy of intensive statin plus intravenous rt-PA in acute ischemic stroke: the INSPIRE randomized clinical trial [J]. J Neurol, 2021, 268(7): 2560-2569.
31
Zhou Z, Xia C, Carcel C, et al. Intensive versus guideline-recommended blood pressure reduction in acute lacunar stroke with intravenous thrombolysis therapy: the ENCHANTED trial [J]. Eur J Neurol, 2021, 28(3): 783-793.
32
Zhong XL, Dong Y, Xu W, et al. Role of blood pressure management in stroke prevention: a systematic review and network meta-analysis of 93 randomized controlled trials [J]. J Stroke, 2021, 23(1): 1-11.
33
Xu J, Wang A, Meng X, et al. Edaravone dexborneol versus edaravone alone for the treatment of acute ischemic stroke: a phase Ⅲ, randomized, double-blind, comparative trial [J]. Stroke, 2021, 52(3): 772-780.
34
Cheng Z, Geng X, Tong Y, et al. Adjuvant high-flow normobaric oxygen after mechanical thrombectomy for anterior circulation stroke: a randomized clinical trial [J]. Neurotherapeutics, 2021, 18(2): 1188-1197.
35
Chen P, Liu TW, Kwong PWH, et al. Bilateral transcutaneous electrical nerve stimulation improves upper limb motor recovery in stroke: a randomized controlled trial [J]. Stroke, 2021, online ahead of print.
36
Tan B, Jia L. Ultrasound-guided BoNT-A (Botulinum Toxin A) injection into the subscapularis for hemiplegic shoulder pain: a randomized, double-blind, placebo-controlled trial [J]. Stroke, 2021, 52(12): 3759-3767.
37
Leung TW, Wang L, Zou X, et al. Plaque morphology in acute symptomatic intracranial atherosclerotic disease [J]. J Neurol Neurosurg Psychiatry, 2021, 92(4): 370-376.
38
Xia C, Zhou J, Lu C, et al. Characterizing diaschisis-related thalamic perfusion and diffusion after middle cerebral artery infarction [J]. Stroke, 2021, 52(7): 2319-2327.
39
Liu L, Wang M, Deng Y, et al. Novel diffusion-weighted imaging score showed good prognostic value for acute basilar artery occlusion following endovascular treatment: the pons-midbrain and thalamus score [J]. Stroke, 2021, 52(12): 3989-3997.
40
Ding Y, Leng X, Nie X, et al. Intraluminal thrombus and outcomes of patients with acute large vessel occlusive stroke undergoing endovascular treatment [J]. Stroke, 2021, 52(4): 1473-1477.
41
Hu R, Zhang C, Xia J, et al. Long-term outcomes and risk factors related to hydrocephalus after intracerebral hemorrhage [J]. Transl Stroke Res, 2021, 12(1): 31-38.
42
Zhao W, Jiang F, Li S, et al. Safety and efficacy of remote ischemic conditioning for the treatment of intracerebral hemorrhage: a proof-of-concept randomized controlled trial [J]. Int J Stroke, 2021, 17474930211006580.
43
Liu J, Nie X, Gu H, et al. Tranexamic acid for acute intracerebral haemorrhage growth based on imaging assessment (TRAIGE): a multicentre, randomised, placebo-controlled trial [J]. Stroke Vasc Neurol, 2021, 6(2): 160-169.
44
Zhao J, Yuan F, Fu F, et al. Hypertension management in elderly with severe intracerebral hemorrhage [J]. Ann Clin Transl Neurol, 2021, 8(10): 2059-2069.
45
Tang L, Yang Q, Liu XL, et al. Mutation analysis of the GLA gene in Chinese patients with intracerebral hemorrhage [J]. Neurobiol Aging, 2021, 102: 220.e1-220.e4.
46
Yang WS, Zhang SQ, Shen YQ, et al. Noncontrast computed tomography markers as predictors of revised hematoma expansion in acute intracerebral hemorrhage [J]. J Am Heart Assoc, 2021, 10(3): e018248.
47
Liao YC, Hu YC, Chung CP, et al. Intracerebral hemorrhage in cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy: prevalence, clinical and neuroimaging features and risk factors [J]. Stroke, 2021, 52(3): 985-993.
48
Jianbo C, Hanqi P, Yihao C, et al. Weakly supervised multitask learning models to identify symptom onset time of unclear-onset intracerebral hemorrhage [J]. Int J Stroke, 2021, 17474930211051531.
49
Sun H, Li W, Xia C, et al. Angiographic and hemodynamic features in asymptomatic hemispheres of patients with Moyamoya disease [J]. Stroke, 2022, 53(1):210-217.
50
Weng JC, Wang J, Du X, et al. Safety of aspirin use in patients with stroke and small unruptured aneurysms [J]. Neurology, 2021, 96(1): e19-e29.
51
Li W, Zhu W, Wang A, et al. Effect of adjusted antiplatelet therapy on preventing ischemic events after stenting for intracranial aneurysms [J]. Stroke, 2021, 52(12): 3815-3825.
52
Lo YL, Li MC, Yu YH, et al. Long-term survival outcomes and prognostic factors related to ruptured intracranial aneurysms: a comparison of surgical and endovascular options in a propensity score-matched, nationwide population-based cohort study [J]. Eur J Neurol, 2021, 28(9): 3012-3021.
53
Ji K, Zhou C, Wu L, et al. Risk factors for severe residual headache in cerebral venous thrombosis [J]. Stroke, 2021, 52(2): 531-536.
54
Feng Y, Yu J, Xu J, et al. Natural history and clinical outcomes of paravertebral arteriovenous shunts [J]. Stroke, 2021, 52(12): 3873-3882.
No related articles found!
阅读次数
全文


摘要